BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20424133)

  • 21. Chemoprevention of prostate cancer.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
    J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can prostate cancer be prevented?
    Klein EA
    Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer prevention trial launched.
    DeFrancesco L
    Nat Med; 2001 Oct; 7(10):1076. PubMed ID: 11590411
    [No Abstract]   [Full Text] [Related]  

  • 24. Nutritional aspects of prostate cancer: a review.
    Blumenfeld AJ; Fleshner N; Casselman B; Trachtenberg J
    Can J Urol; 2000 Feb; 7(1):927-35; discussion 936. PubMed ID: 11121247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical review of complementary therapies for prostate cancer.
    Wilkinson S; Chodak GW
    J Clin Oncol; 2003 Jun; 21(11):2199-210. PubMed ID: 12775747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A genetics perspective on prostate cancer.
    Lessick M; Katz A
    Urol Nurs; 2006 Dec; 26(6):454-60. PubMed ID: 17253080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase III prostate cancer prevention trials: are the costs justified?
    Thompson IM; Tangen CM; Klein EA; Lippman SM
    J Clin Oncol; 2005 Nov; 23(32):8161-4. PubMed ID: 16278467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin E and prostate cancer: research focus turns to biologic mechanisms.
    McNeil C
    J Natl Cancer Inst; 2011 Dec; 103(23):1731-4. PubMed ID: 22100581
    [No Abstract]   [Full Text] [Related]  

  • 30. Selenium and risk of prostate cancer.
    Giovannucci E
    Lancet; 1998 Sep; 352(9130):755-6. PubMed ID: 9737275
    [No Abstract]   [Full Text] [Related]  

  • 31. Selenitetriglycerides-Redox-active agents.
    Flis A; Suchocki P; Królikowska MA; Suchocka Z; Remiszewska M; Śliwka L; Książek I; Sitarz K; Sochacka M; Hoser G; Anuszewska E; Wroczyński P; Jastrzębski Z
    Pharmacol Rep; 2015 Feb; 67(1):1-8. PubMed ID: 25560568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.
    Facompre N; El-Bayoumy K
    Cancer Res; 2009 Apr; 69(7):2699-703. PubMed ID: 19318549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenium cytotoxicity in cancer.
    Wallenberg M; Misra S; Björnstedt M
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):377-86. PubMed ID: 24529300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics in breast and prostate cancer: assessment of the current state and future perspectives.
    Mehrian-Shai R; Reichardt JK
    Future Oncol; 2006 Jun; 2(3):357-62. PubMed ID: 16787115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boosting and lassoing new prostate cancer SNP risk factors and their connection to selenium.
    Booth DE; Gopalakrishna-Remani V; Cooper ML; Green FR; Rayman MP
    Sci Rep; 2021 Sep; 11(1):17877. PubMed ID: 34504230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status of selenium in prostate cancer prevention.
    Combs GF
    Br J Cancer; 2004 Jul; 91(2):195-9. PubMed ID: 15213714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimising Selenium for Modulation of Cancer Treatments.
    Evans SO; Khairuddin PF; Jameson MB
    Anticancer Res; 2017 Dec; 37(12):6497-6509. PubMed ID: 29187424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The innovative potential of selenium-containing agents for fighting cancer and viral infections.
    Ali W; Benedetti R; Handzlik J; Zwergel C; Battistelli C
    Drug Discov Today; 2021 Jan; 26(1):256-263. PubMed ID: 33164821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epidemiology of Selenium and Human Cancer.
    Vinceti M; Filippini T; Cilloni S; Crespi CM
    Adv Cancer Res; 2017; 136():1-48. PubMed ID: 29054414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New concepts in selenium chemoprevention.
    Ip C; Dong Y; Ganther HE
    Cancer Metastasis Rev; 2002; 21(3-4):281-9. PubMed ID: 12549766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.